38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely fentanyl 1.2 milligram/1 each conventional release buccal film (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely fentanyl 1.2 milligram/1 each conventional release buccal film (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Benserazide 25 mg and levodopa 100 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Benserazide 25 mg and levodopa 100 mg oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Pentobarbital sodium 30 mg rectal suppository	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Pentobarbital sodium 30 mg rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paracetamol 250 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Paracetamol 250 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Vidarabine 30 mg/g eye ointment	Count of base of active ingredient	False	1	Inferred relationship	Some
Vidarabine 30 mg/g eye ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely sodium salicylate 325 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely sodium salicylate 325 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Ranitidine (as ranitidine hydrochloride) 75 mg effervescent oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Sulfacetamide sodium 150 mg/mL eye solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Sulfacetamide sodium 150 mg/mL eye solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Naphazoline hydrochloride 1 mg/mL eye solution	Has concentration strength numerator value	False	1	Inferred relationship	Some	1
Naphazoline hydrochloride 1 mg/mL eye solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Naphazoline hydrochloride 1 mg/mL eye solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Duloxetine (as duloxetine hydrochloride) 20 mg gastro-resistant oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Duloxetine (as duloxetine hydrochloride) 20 mg gastro-resistant oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	3
Clotrimazole 10 mg/mL vaginal cream	Count of base of active ingredient	False	1	Inferred relationship	Some
Clotrimazole 10 mg/mL vaginal cream	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Estropipate only product	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Tobramycin 3 mg/mL eye solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Tobramycin 3 mg/mL eye solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Phenylephrine hydrochloride 100 mg/mL eye solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Phenylephrine hydrochloride 100 mg/mL eye solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Trazodone hydrochloride 150 mg prolonged-release oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Trazodone hydrochloride 150 mg prolonged-release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Phenytoin sodium 200 mg prolonged-release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Some
Phenytoin sodium 200 mg prolonged-release oral capsule	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bepotastine besilate 15 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing only fentanyl in oromucosal dose form (medicinal product form)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azelastine hydrochloride 500 microgram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Clindamycin phosphate 20 mg/mL vaginal cream	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Clindamycin phosphate 20 mg/mL vaginal cream	Count of base of active ingredient	False	1	Inferred relationship	Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Diphenhydramine hydrochloride 12.5 mg chewable tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Diphenhydramine hydrochloride 12.5 mg chewable tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Mirtazapine 15 mg orodispersible tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Mirtazapine 15 mg orodispersible tablet	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet	Has presentation strength denominator value	False	1	Inferred relationship	Some	2

Start Previous Page 171 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core